Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
VintaBio
AddedFeb 17, 2024
UpdatedJun 18, 2026
VintaBio

VintaBio

VintaBio: Expert CDMO provider for viral vectors, advancing cell and gene therapy manufacturing.

HQ
Philadelphia, PA, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

VintaBio, founded by Dr. Shangzhen Zhou, is a Contract Development and Manufacturing Organization (CDMO) specializing in the production of GMP-grade and research-grade viral vectors. The company’s core mission is to alleviate the viral vector bottleneck in cell and gene therapy development, thereby accelerating the advancement of these transformative therapies. VintaBio provides comprehensive manufacturing services tailored to pharmaceutical and biotechnology organizations, ensuring high-quality vector production and fostering trust and transparency throughout the development process.

Notable affiliated individuals include Dr. Shangzhen Zhou, whose expertise drives the company’s innovative approach. VintaBio has made significant strides in the life sciences sector by addressing critical challenges in cell and gene therapy manufacturing. Their impact is evidenced by their ability to streamline the production process, thereby expediting the delivery of vital therapies to patients. Through their specialized services, VintaBio has positioned itself as a key player in the biopharmaceutical industry, contributing to the advancement of cutting-edge medical treatments.

VintaBio - Similar Companies

Vector Biomed logo

Vector Biomed

vectorbiomed.com

Center for Breakthrough Medicines logo

Center for Breakthrough Medicines

Vineti logo

Vineti

Andelyn Biosciences logo

Andelyn Biosciences

andelynbio.com

VectorBuilder logo

VectorBuilder

vectorbuilder.com

ViTToria Biotherapeutics logo

ViTToria Biotherapeutics

vittoriabio.com

64x Bio logo

64x Bio

64xbio.com

PackGene Biotech logo

PackGene Biotech

packgene.com

Synvivia logo

Synvivia

synvivia.com

Virion Therapeutics logo

Virion Therapeutics

viriontx.com

Virogenomics logo

Virogenomics

virogenomics.com

Via Nova Therapeutics logo

Via Nova Therapeutics

vianovatx.com

iVexSol logo

iVexSol

ivexsol.com

Retrovirox logo

Retrovirox

retrovirox.com

Vir Biotechnology logo

Vir Biotechnology

vir.bio

VintaBio - Quick Facts

Who are VintaBio's competitors?

Companies similar to VintaBio include Vector Biomed, Center for Breakthrough Medicines, Vineti and Andelyn Biosciences.

When was VintaBio founded?

VintaBio was founded in 2020.

Where is VintaBio's headquarters located?

VintaBio's headquarters is located in Philadelphia, PA, US.

When was VintaBio's last funding round?

VintaBio's most recent funding round was for $64M (USD) in April 2023.

How much has VintaBio raised to-date?

As of Apr 11, 2023, VintaBio has raised a total of $64M (USD).

How many employees does VintaBio have?

VintaBio has 15 employees as of Feb 4, 2024.

VintaBio - Classification

Industry
  • Professional Service Companies
Technology
  • Biotech
Geographic Exposure
  • Global
Customer
  • Enterprise
Main Product
  • Viral Vectors
Tags
  • CDMO
  • Consulting
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 15 more industry codes
NAICS
  • 513200Software Publishers
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 541700Scientific Research and Development Services
  • 513210Software Publishers
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 7372Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research